GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹3,454 Cr | ₹3,252 Cr | ₹3,278 Cr | ₹2,926 Cr | ₹3,224 Cr |
What is the latest Revenue of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2025 | ₹3,454 Cr |
Mar2024 | ₹3,252 Cr |
Mar2023 | ₹3,278 Cr |
Mar2022 | ₹2,926 Cr |
Mar2021 | ₹3,224 Cr |
How is Revenue of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹3,454 Cr | 6.21 | |
Mar2024 | ₹3,252 Cr | -0.80 | |
Mar2023 | ₹3,278 Cr | 12.05 | |
Mar2022 | ₹2,926 Cr | -9.27 | |
Mar2021 | ₹3,224 Cr | - |
Compare Revenue of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹53,441.5 Cr | 1.2% | -4.3% | 17.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 1.2% |
-4.3% |
17.3% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses